pyrroles has been researched along with Overweight in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloigu, R; Morin-Papunen, L; Piltonen, T; Puukka, K; Puurunen, J; Ruokonen, A; Savolainen, MJ; Tapanainen, JS | 1 |
| Davy, KP; Dengo, AL; Orr, JS; Rivero, JM | 1 |
| Bays, HE; Choi, YJ; Karpf, DB; Kerzner, B; Krauss, RM; Littlejohn, T; Naim, S; Roberts, BK; Schwartz, S; Wang, X | 1 |
| Choi, YJ; Geaney, JC; Karpf, DB; Krauss, RM; Naim, S; Roberts, BK; Wang, X; Wojnoonski, K | 1 |
| Aldama-López, G; Campo-Pérez, R; Castro-Beiras, A; Crespo-Leiro, MG; Llinares-García, D; Marzoa-Rivas, R; Muñiz-Garcia, J; Paniagua-Marin, MJ; Piñón-Esteban, P | 1 |
| Burggraaf, J; Cohen, AF; Dirsch, V; Espirito Santo, SM; Gebhardt, R; Haffner, T; Kamerling, IM; Meijer, P; Princen, HM; Schoemaker, RC; van Doorn, MB; Vollmar, A | 1 |
5 trial(s) available for pyrroles and Overweight
| Article | Year |
|---|---|
Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Body Mass Index; Double-Blind Method; Female; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Hyperinsulinism; Hyperlipidemias; Insulin Resistance; Insulin-Secreting Cells; Middle Aged; Overweight; Polycystic Ovary Syndrome; Pyrroles | 2013 |
Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults.
Topics: Adult; Aged; Aging; Atorvastatin; Blood Flow Velocity; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Double-Blind Method; Elasticity; Female; Femoral Artery; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Obesity; Overweight; Pyrroles; Regional Blood Flow; Risk Factors | 2009 |
MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.
Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Liver; Male; Middle Aged; Overweight; PPAR delta; Pyrroles; Treatment Outcome | 2011 |
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia.
Topics: Acetates; Analysis of Variance; Atherosclerosis; Atorvastatin; Biomarkers; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Particle Size; PPAR gamma; Pyrroles; Time Factors; Treatment Outcome; Triazoles | 2012 |
Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects.
Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Endothelium; Female; Garlic; Heptanoic Acids; Humans; Lipids; Male; Middle Aged; Overweight; Plant Extracts; Powders; Pyrroles; Smoking; Triglycerides | 2006 |
1 other study(ies) available for pyrroles and Overweight
| Article | Year |
|---|---|
Safety of statins when response is carefully monitored: a study of 336 heart recipients.
Topics: Adolescent; Adult; Anticholesteremic Agents; Atorvastatin; Body Mass Index; Graft Rejection; Heart Transplantation; Heptanoic Acids; Humans; Middle Aged; Overweight; Pravastatin; Pyrroles; Retrospective Studies; Safety | 2005 |